IPO

IP Group portfolio company Istesso begins Phase 2 trial of leramistat

Istesso has started dosing in a Phase 2 trial of leramistat in rheumatoid arthritis-related sarcopenia, evaluating its effects on muscle quality, repair and function...

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

IP Group sees revenue potential from Metsera obesity drug deal

IP Group plc has outlined potential future revenue opportunities from obesity drug candidates developed by Metsera, following Pfizer’s agreement to acquire Metsera for up to $7.3 billion...

IP Group Plc two quoted life sciences portfolio companies receive cash offers

IP Group plc celebrates cash offers for life sciences portfolio firms, expecting significant returns to fuel further investment and share buybacks...

IP Group strong balance sheet maintained and well-funded portfolio

IP Group plc (LON:IPO), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has announced its financial results for the six..

IP Group recommends a final dividend of 0.76p per share

IP Group plc (LON:IPO), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has issued the following statement ahead of its..

IP Group portfolio company AMSL Aero’s Vertiia successfully completes maiden test flight

IP Group plc (LON:IPO), which develops world-changing science and technology businesses, has noted that Australian portfolio company AMSL Aero has announced that Vertiia has successfully completed its maiden test flight...

Market Overview: Go-Ahead, IP Group, Homeserve and Moonpig

Todays news affecting the financial and crypto markets today. UK Market A slightly negative start is expected for equity markets this morning with the FTSE100 called to open with losses..

IP Group portfolio company First Light achieves fusion

IP Group plc (LON:IPO), which develops world-changing science and technology businesses across life sciences, technology and cleantech, has noted that portfolio company First Light Fusion Ltd has confirmed that it..

IP Group Chief Executive Officer and Chief Investment Officer step down

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, has today announced that following the successful flotation of the Group’s largest holding, Oxford Nanopore Technologies plc (LON:ONT), Alan Aubrey,..

IP Group’s day-to-day operations largely unaffected in the year to date

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, has issued the following statement ahead of its Annual General Meeting which will take place at 11am today. This statement..

IP Group plc – Portfolio company Oxford Nanopore Technologies announces £48.4m of additional funding

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, noted today that its portfolio company Oxford Nanopore Technologies Limited, has announced that it has raised an additional £48.4 million..

IP Group sells 12.25m shares in Ceres Power

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, announced today that it has sold 12.25 million ordinary shares in Ceres Power Holdings plc (LON:CWR) at a price of..

IP Group announces that Jonathan Brooks is retiring

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, announced today that Jonathan Brooks is retiring from his position as a non-executive director after nearly nine years in the..

Airtel Africa Results of the IPO of Airtel Malawi plc

Airtel Africa plc (LON:AAF) a leading provider of telecommunications and mobile money services, with a presence in 14 countries across Africa, further to its announcement on 24 December 2019, today..

IP Group plc Portfolio company Istesso announces positive outcome from Phase 2a study

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, has today noted that portfolio company Istesso Limited has announced positive headline results from its Phase 2a study of its..

IP Group plc Portfolio company Ceres Power and Doosan sign collaboration

IP Group plc (LON:IPO), the developer of intellectual property-based businesses, has today noted that portfolio company Ceres Power Holdings plc and Doosan Corporation, have signed a collaboration and licensing agreement..

IP Group plc – Appointment of Aedhmar Hynes as Non-executive Director

IP Group plc (LON: IPO), the developer of intellectual property-based businesses, has today announced the appointment of Aedhmar Hynes as an independent Non-executive Director with effect from 1 August 2019...

IP Group plc Diurnal positive advice from EMA for Chronocort

IP Group plc (LON: IPO), the developer of intellectual property-based businesses, notes the announcement by its portfolio company Diurnal Group plcthat, following a positive meeting with the European Medicines Agency..

IP Group plc Loss for the year of £90.6m

IP Group plc (LON: IPO), the developer of intellectual property-based businesses, today announces its annual financial results for the year ended 31 December 2018. Portfolio highlights · Fair value of..

Search

Funds

IPO

IP Group portfolio company Istesso begins Phase 2 trial of leramistat

Istesso has started dosing in a Phase 2 trial of leramistat in rheumatoid arthritis-related sarcopenia, evaluating its effects on muscle quality, repair and function...

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

IP Group sees revenue potential from Metsera obesity drug deal

IP Group plc has outlined potential future revenue opportunities from obesity drug candidates developed by Metsera, following Pfizer’s agreement to acquire Metsera for up to $7.3 billion...

IP Group Plc two quoted life sciences portfolio companies receive cash offers

IP Group plc celebrates cash offers for life sciences portfolio firms, expecting significant returns to fuel further investment and share buybacks...
Search

Funds

IPO

FTSE 100

Funds